SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

SHL.DE

50.26

-0.95%↓

ARGX

488.1

+0.16%↑

VIE

29.64

-1%↓

BNR

64.2

-2.1%↓

GLPG

24.94

-1.97%↓

Home・Stock List・Sanofi SA

Sanofi SA

Closed

Sector Healthcare

104.78 -0.46

Buy Sell

Overview

Share price change

24h

Current

Min

104.7

Max

105.74

Key metrics
By Trading Economics
Income	1.1B
Sales	916M 11B
P/E Sector Avg	24.91 103.001
EPS	1.73
Profit margin	9.78
EBITDA	-136M 2B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+3.32 upside

Dividends
By Dow Jones
Next Earnings	25 Oct 2024

Market Stats
By TradingEconomics
Market Cap	131B
Previous open	105.24
Previous close	104.78

News Sentiment

By Acuity

50%

114 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

104.9 / 105.78 Support & Resistance

Sanofi SA Chart

Related News

25 Jul 2024, 05:44 UTC

Earnings

Sanofi Raises Guidance After Profit, Sales Beat

24 Jul 2024, 10:24 UTC

Earnings

Spanish Bank Santander Raises 2024 Guidance After Earnings Beat -- Update

24 Jul 2024, 05:22 UTC

Earnings

Santander Raises 2024 Revenue Guidance After Earnings Increase

4 Jul 2024, 06:44 UTC

Acquisitions, Mergers, Takeovers

Bain, Cinven Explore Joint Bid for Sanofi's Consumer Unit, Bloomberg Reports

27 Jun 2024, 10:54 UTC

Major Market Movers

Vigil Neuroscience Shares Soar on $40 Million Sanofi Investment

15 Aug 2024, 08:21 UTC

Market Talk

Earnings

European Banks' Net Interest Income Momentum May Have Stalled -- Market Talk

14 Aug 2024, 07:07 UTC

Market Talk

Southern European Banks Have Attractive Net Interest Income Dynamics -- Market Talk

26 Jul 2024, 12:53 UTC

Market Talk

Earnings

European Banks' Earnings Season Had Another Good Start -- Market Talk

25 Jul 2024, 13:20 UTC

Earnings

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

25 Jul 2024, 11:46 UTC

Market Talk

Earnings

Sanofi Aims to Boost RSV Drug Supply -- Market Talk

25 Jul 2024, 11:23 UTC

Market Talk

Earnings

Sanofi Results Are Positive -- Market Talk

25 Jul 2024, 05:33 UTC

Earnings

Analysts Saw Sanofi 2Q Sales at EUR10.4B

25 Jul 2024, 05:33 UTC

Earnings

Sanofi 2Q Sales EUR10.745B

25 Jul 2024, 05:30 UTC

Earnings

Sanofi Had Seen 2024 Business Earnings Per Share Decreasing Low Single Digit at Constant Currency

25 Jul 2024, 05:30 UTC

Earnings

Sanofi Now Expects 2024 Business Earnings Per Share to Be Stable at Constant Currency

25 Jul 2024, 05:30 UTC

Earnings

Analysts Saw Sanofi 2Q Business Operating Income at EUR2.69B

25 Jul 2024, 05:30 UTC

Earnings

Sanofi 2Q Net Pft EUR1.11B

25 Jul 2024, 05:30 UTC

Earnings

Sanofi Raises 2024 View

25 Jul 2024, 05:30 UTC

Earnings

Sanofi 2Q Business Operating Income EUR2.81B

24 Jul 2024, 06:53 UTC

Market Talk

Earnings

Santander's Small Beats, Improved Outlook Should Be Well Received -- Market Talk

24 Jul 2024, 04:50 UTC

Earnings

Santander Raises 2024 Rev View

24 Jul 2024, 04:50 UTC

Earnings

Santander Fully-Loaded CET1 Ratio 12.5% at 2Q-End

24 Jul 2024, 04:48 UTC

Earnings

Santander 2Q Net Interest Income Fell 4.2%

24 Jul 2024, 04:48 UTC

Earnings

Santander 2Q Net Interest Income EUR11.47B

24 Jul 2024, 04:48 UTC

Earnings

Santander 2Q Net Pft EUR3.21B

24 Jul 2024, 04:47 UTC

Earnings

Santander 2Q Rev EUR15.67B

9 Jul 2024, 09:05 UTC

Peer Comparison

Price change

Sanofi SA Forecast

Price Target

By TipRanks

3.32% upside

12 Months Forecast

Average 108.4 EUR 3.32%

High 125 EUR

Low 85 EUR

Based on 12 Wall Street analysts offering 12 month price targets forSanofi SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to Sanofi SA - Dist in the past 3 months.

Technical Score

By Trading Central

104.9 / 105.78Support & Resistance

Bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

114 / 365 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

About Sanofi SA

Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.